☰

Priyanka Duttagupta, Ph.D. - Publications

Affiliations: 
2011 Drexel University College of Medicine, Philadelphia, PA, United States 
Area:
HIV, CD8 T cell
Tree Info Grants Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, Lanitis E, Duraiswamy J, Tanyi JL, Benencia F, Conejo-Garcia J, Ramay HR, Montone KT, Powell DJ, Gimotty PA, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 35: 885-900.e10. PMID 31185212 DOI: 10.1016/J.Ccell.2019.05.004  0.378
2019 Adashek JJ, Won H, Moreira D, Duttagupta P, Twardowski P, Jones J, Kortylewski M, Pal SK. Effect of IL-6 and related mediators on resistance to abiraterone acetate (abi) and enzalutamide (enza) in patients with metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 37: 296-296. DOI: 10.1200/Jco.2019.37.7_Suppl.296  0.46
2018 Kortylewski M, Duttagupta P, SU Y, Adamus T, Marcucci G. STAT3 Inhibition Enables TLR9-Driven Differentiation of Cbfb/Myh11 acute Myeloid Leukemia Cells to Antigen-Presenting Cell Phenotype In Vivo Blood. 132: 4070-4070. DOI: 10.1182/Blood-2018-99-119771  0.497
2017 Won H, Moreira D, Gao C, Duttagupta P, Zhao X, Manuel E, Diamond D, Yuan YC, Liu Z, Jones J, D'Apuzzo M, Pal S, Kortylewski M. TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs. Journal of Leukocyte Biology. PMID 28533357 DOI: 10.1189/Jlb.3Ma1016-451Rr  0.357
2016 Curran E, Chen X, Corrales L, Kline DE, Dubensky TW, Duttagupta P, Kortylewski M, Kline J. STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia. Cell Reports. PMID 27264175 DOI: 10.1016/J.Celrep.2016.05.023  0.427
2016 Zhang Q, Hossain DM, Duttagupta P, Moreira D, Zhao X, Won H, Buettner R, Nechaev S, Majka M, Zhang B, Cai Q, Swiderski P, Kuo YH, Forman S, Marcucci G, et al. Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia. Blood. PMID 26796361 DOI: 10.1182/Blood-2015-08-665604  0.509
2016 Moreira D, Zhao X, Won H, Duttagupta P, Pal S, Kortylewski M. 261. Gain-of-Function Effect Augments Therapeutic Efficacy of CpG-STAT3 Anti-Sense Oligonucleotide Against Castration-Resistant Prostate Cancers Molecular Therapy. 24: S103. DOI: 10.1016/S1525-0016(16)33070-2  0.403
2015 Hossain DM, Pal SK, Moreira D, Duttagupta P, Zhang Q, Won H, Jones J, D'Apuzzo M, Forman S, Kortylewski M. TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 25967142 DOI: 10.1158/1078-0432.Ccr-14-3145  0.419
2015 Zsiros E, Duttagupta P, Dangaj D, Li H, Frank R, Garrabrant T, Hagemann IS, Levine BL, June CH, Zhang L, Wang E, Marincola FM, Bedognetti D, Powell DJ, Tanyi J, et al. The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2840-50. PMID 25712684 DOI: 10.1158/1078-0432.Ccr-14-2777  0.618
2015 Sakib Hossain DM, Duttagupta P, Kortylewski M. The aptamer-siRNA conjugates: reprogramming T cells for cancer therapy. Therapeutic Delivery. 6: 1-4. PMID 25565435 DOI: 10.4155/Tde.14.92  0.537
2015 Zhang Q, Hossain S, Moreira D, Duttagupta P, Zhao X, Swiderski P, Kortylewski M. Cell-selective oligonucleotide STAT3 inhibitor for immunotherapy of human acute myeloid leukemia Journal For Immunotherapy of Cancer. 3: P362. DOI: 10.1186/2051-1426-3-S2-P362  0.458
2014 Zsiros E, Duttagupta P, Garrabrant T, Tanyi JL, Kandalaft LE, Coukos G. Abstract 1071: Adoptive transfer of T cells overcomes barriers of homing to the tumor microenvironment in ovarian cancer Cancer Research. 74: 1071-1071. DOI: 10.1158/1538-7445.Am2014-1071  0.612
2014 Zsiros E, Duttagupta P, Garrabrant T, Tanyi J, Kandalaft L, Coukos G. T cells prepared for adoptive transfer therapy have enhanced homing ability to ovarian cancer microenvironment Gynecologic Oncology. 133: 176-177. DOI: 10.1016/J.Ygyno.2014.03.465  0.414
2013 Zsiros E, Lee H, Hagemann IS, Duttagupta P, Frank R, Garrabrant T, Levine BL, June CH, Tanyi J, Kandalaft L, Feldman M, Coukos G. Abstract 3968: Ovarian cancer chemokine microenvironment is conducive to homing of CD3/CD28 co-stimulated T cells prepared for adoptive transfer therapy. Cancer Research. 73: 3968-3968. DOI: 10.1158/1538-7445.Am2013-3968  0.642
2013 Zsiros E, Duttagupta P, Garrabrant T, Levine B, Tanyi J, Kandalaft L, Coukos G. Chemokine receptors enhance T-cell vaccine cell homing to ovarian cancer Gynecologic Oncology. 130: e135. DOI: 10.1016/J.Ygyno.2013.04.384  0.427
2011 Dolfi DV, Duttagupta PA, Boesteanu AC, Mueller YM, Oliai CH, Borowski AB, Katsikis PD. Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo. Journal of Immunology (Baltimore, Md. : 1950). 186: 4599-608. PMID 21389258 DOI: 10.4049/Jimmunol.1001972  0.403
2009 Duttagupta PA, Boesteanu AC, Katsikis PD. Costimulation signals for memory CD8+ T cells during viral infections. Critical Reviews in Immunology. 29: 469-86. PMID 20121696 DOI: 10.1615/Critrevimmunol.V29.I6.20  0.711
Show low-probability matches.